Skip to main content
OpenTrials

Clinical trial condition

Castration Resistant Prostate Cancer

Explore clinical trials studying Castration Resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

12 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Castration Resistant Prostate Cancer trial results

Completed

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

NCT04580485

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +59 more
Locations
  • Cedars-Sinai Medical Center West Hollywood, California, United States
  • University of Maryland-Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 27 locations
View Trial Details
Completed

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

NCT03473925

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Honor Health ( Site 0005) Scottsdale, Arizona, United States
  • Florida Cancer Specialists ( Site 0003) Sarasota, Florida, United States
  • University of Maryland ( Site 0008) Baltimore, Maryland, United States
  • Henry Ford Health System ( Site 0006) Detroit, Michigan, United States
View all 14 locations
View Trial Details
Completed

Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer

NCT02833883

Conditions
Castration Resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • John Hopkins Medical Center Baltimore, Maryland, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate Cancer

NCT01646684

Conditions
Castration Resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +8 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Dresden, Germany
  • Novartis Investigative Site Hamburg, Germany
  • Novartis Investigative Site Tübingen, Germany
View Trial Details
Completed

A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)

NCT02384382

Conditions
Castration Resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute Weisberg Cancer Treatment Center Farmington Hills, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Wimr Pet/Ct Madison, Wisconsin, United States
View Trial Details

Related conditions